Evidence map›Paper›PMID 42015330›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Diffusion weighted imaging abnormalities and cerebral ischemia in a cohort of patients on lecanemab.

Dylan Ryan, Michael W Lutz, Tori Sides, Richard O'Brien, Kim Johnson

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dylan RyanDepartment of Neurology, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0001-7254-0020
Michael W LutzDepartment of Neurology, Duke University School of Medicine, Durham, North Carolina, USA.
Tori SidesDepartment of Neurology, Duke University School of Medicine, Durham, North Carolina, USA.
Richard O'BrienDepartment of Neurology, Duke University School of Medicine, Durham, North Carolina, USA.
Kim JohnsonDepartment of Neurology, Duke University School of Medicine, Durham, North Carolina, USA.

Funding

Research Education Component CoreP30AG072958 · NIA · DUKE UNIVERSITY · PI Heather E. Whitson · 2021 to 2026
$24.1M
NIA NIH HHS P30 AG072958NIA NIH HHS P30AG072958
6 · The paper itself

Abstract

introductionWe evaluate the frequency of diffusion weighted imaging abnormalities consistent with stroke in patients on lecanemab, focusing on the association between amyloid-related imaging abnormalities (ARIAs) and stroke incidence.

methodsFor this retrospective cohort study, data were collected from time of lecanemab initiation to last follow-up. Descriptive statistics characterized demographic and clinical factors for patients who experienced interval stroke in contrast to individuals who did not experience stroke. Propensity score matching was performed to evaluate the association between ARIAs and stroke accounting for confounding factors.

resultsOf 261 patients, 11 (4.2%) were diagnosed with interval stroke. Stroke patients were older (80.1 vs. 74.3 years had lower median Montreal Cognitive Assessment cognitive scores (19 vs. 22) and higher prevalence of ARIAs (54.5% vs. 20.8%). A significant association (P = 0.011) was observed between ARIAs and stroke incidence after propensity score matching. Strokes were small, asymptomatic, and mostly cerebellar (36.4%) or cortical (36.4%). DISCUSSION: Diagnosis of an ARIA was significantly associated with increased stroke. Higher than expected rates of cerebellar and cortical stroke and relationship to ARIAs suggests a possible common, immune-mediated mechanism between these regions of restricted diffusion and ARIAs. Further study is warranted.

Indexed as

Brain IschemiaDiffusion Magnetic Resonance ImagingStrokeAgedAged, 80 and overCohort StudiesFemaleHumansIncidenceMaleRetrospective Studiesamyloid‐related imaging abnormalitiescerebral amyloid angiopathydiffusion weighted imaginglecanemabstroke

Identifiers

PMID42015330
PMCPMC13099582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.